Restoration

EP3570840

COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    19.1.2018
  • :
    19.3.2025
  • :
    18709192.1
  • :
    18.1.2038
  • :
    COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

19.1.2018
19.3.2025
  • :
    Exelixis, Inc.
  • :
    1851 Harbor Bay Parkway, Alameda, CA 94502, US
  • :
    SCHWAB, Gisela
  • :
    Hayward CA 94541, US
  • :
    SCHEFFOLD, Christian
  • :
    Palo Alto CA 94306, US
  • :
    HESSEL, Colin
  • :
    Redwood City CA 94061, US
  • :
    201762448869 P
  • :
    20.1.2017
  • :
    US
  • :
    201762458447 P
  • :
    13.2.2017
  • :
    US
  • :
    US2018014523
  • :
    19.1.2018
  • :
    A61K 31/47, A61K 39/39, A61K 9/20, A61K 39/00, A61K 39/395, A61K 45/06, A61P 35/00, A61P 35/04, C07K 16/28